Explore more publications!

Comoros Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.

Press releases published on April 28, 2026

Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
Crypto News Today: AlphaPepe Presale Hits $1M Raised as XRP Price Prediction Targets $13
BIGG Digital Assets Inc. Reports Audited Financial Results for Fiscal Year 2025
Seven Shareholder Questions Tyler Proud Needs to Answer
Waldencast announces conclusion of SEC investigation
Leading CDMO Selects Kneat to Power Digital Validation Transformation
Trident Filed 2025 Annual Report on Form 20-F
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
Stride reports third quarter 2026 financial results
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Myseum.AI Appoints Ian Goldberg as Head of Marketing, Partnerships & Monetization
Varonis Announces First Quarter 2026 Financial Results
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Aandeelhouders van Galapagos keuren alle door de Raad van Bestuur  voorgestelde besluiten goed op de Gewone en Buitengewone Algemene Vergaderingen van 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions